These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30562585)

  • 1. Modified cells as potential ocular drug delivery systems.
    Tennikova T; Urtti A
    Drug Discov Today; 2019 Aug; 24(8):1621-1626. PubMed ID: 30562585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein conjugates and fusion proteins as ocular therapeutics.
    Mehta SC; Kelley RF; Tesar DB
    Drug Discov Today; 2019 Aug; 24(8):1440-1445. PubMed ID: 31202674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety evaluation of long-acting ocular delivery systems.
    Thackaberry EA; Lorget F; Farman C; Bantseev V
    Drug Discov Today; 2019 Aug; 24(8):1539-1550. PubMed ID: 31173909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled and continuous release ocular drug delivery systems: pros and cons.
    Abdelkader H; Alany RG
    Curr Drug Deliv; 2012 Jul; 9(4):421-30. PubMed ID: 22640036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogels for sustained delivery of biologics to the back of the eye.
    Chang D; Park K; Famili A
    Drug Discov Today; 2019 Aug; 24(8):1470-1482. PubMed ID: 31202673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery to the posterior segment of the eye.
    Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
    Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery.
    Than A; Liu C; Chang H; Duong PK; Cheung CMG; Xu C; Wang X; Chen P
    Nat Commun; 2018 Nov; 9(1):4433. PubMed ID: 30401883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond.
    Destruel PL; Zeng N; Maury M; Mignet N; Boudy V
    Drug Discov Today; 2017 Apr; 22(4):638-651. PubMed ID: 28017837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depot formulations to sustain periocular drug delivery to the posterior eye segment.
    Agban Y; Thakur SS; Mugisho OO; Rupenthal ID
    Drug Discov Today; 2019 Aug; 24(8):1458-1469. PubMed ID: 30930148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gap between the need for novel retinal drug delivery methods, technologies in R&D phase, and approved ocular drug delivery technologies.
    Neumann R; Barequet D
    Drug Discov Today; 2019 Aug; 24(8):1433-1435. PubMed ID: 30904724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell penetrating peptides in ocular drug delivery: State of the art.
    Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
    J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancements in ocular drug delivery.
    Weiner AL; Gilger BC
    Vet Ophthalmol; 2010 Nov; 13(6):395-406. PubMed ID: 21182726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
    Shen J; Lu GW; Hughes P
    Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implants for drug delivery to the posterior segment of the eye: a focus on stimuli-responsive and tunable release systems.
    Yasin MN; Svirskis D; Seyfoddin A; Rupenthal ID
    J Control Release; 2014 Dec; 196():208-21. PubMed ID: 25307997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role for drug delivery in the development of new ophthalmic treatments.
    Sheardown H
    Future Med Chem; 2012 Nov; 4(17):2123-5. PubMed ID: 23190096
    [No Abstract]   [Full Text] [Related]  

  • 17. In situ gelling polymers in ocular drug delivery systems: a review.
    Mundada AS; Avari JG
    Crit Rev Ther Drug Carrier Syst; 2009; 26(1):85-118. PubMed ID: 19496748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iontophoresis: a non-invasive ocular drug delivery.
    Eljarrat-Binstock E; Domb AJ
    J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarriers in ocular drug delivery: an update review.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advance of the application of nano-controlled release system in ophthalmic drug delivery.
    Wang X; Wang S; Zhang Y
    Drug Deliv; 2016 Oct; 23(8):2897-2901. PubMed ID: 26635087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.